Skip to Content

Month: October 2021

Russia’s new COVID-19 infections, deaths near all-time highs

By VLADIMIR ISACHENKOV Associated Press MOSCOW (AP) — Russia’s daily coronavirus infections and deaths are hovering near all-time highs amid a lagging vaccination rate and the Kremlin’s reluctance to toughen restrictions. Russia’s state coronavirus task force reported 29,409 new confirmed cases Monday. That’s the highest number this year and just slightly lower than the pandemic

Continue Reading

Russia’s new COVID-19 infections, deaths near all-time highs

By VLADIMIR ISACHENKOV Associated Press MOSCOW (AP) — Russia’s daily coronavirus infections and deaths are hovering near all-time highs amid a lagging vaccination rate and the Kremlin’s reluctance to toughen restrictions. Russia’s state coronavirus task force reported 29,409 new confirmed cases Monday. That’s the highest number this year and just slightly lower than the pandemic

Continue Reading

Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravir

By Jamie Gumbrecht and Maggie Fox, CNN Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. If authorization is granted, the drug, made by Merck and Ridgeback Biotherapeutics, would be the first oral antiviral treatment to fight Covid-19. It comes in capsule form.

Continue Reading

Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravir

CNN By Jamie Gumbrecht and Maggie Fox, CNN Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. If authorization is granted, the drug, made by Merck and Ridgeback Biotherapeutics, would be the first oral antiviral treatment to fight Covid-19. It comes in capsule

Continue Reading